Table 1.
Clinical and pathological characteristics of patient populations
| NPT | BPH | HGPIN | PCa | |
|---|---|---|---|---|
| Number of patients |
10 |
26 |
37 |
121 |
| Age, median (range) |
60 (50–80) |
68 (54–79) |
65 (40–74) |
64 (40–74) |
| PSA, ng/mL, median (range) |
n.av. |
5.8 (0.8-32.5) |
8.03 (3.35-16.9) |
9.3 (3.1-48.3) |
| Gleason score, median (range) |
n.a. |
n.a. |
n.a. |
7 (4–9) |
| Pathological stage (%) |
|
|
|
|
| pT2 |
n.a. |
n.a. |
n.a. |
63 (52.1%) |
| pT3 | n.a. | n.a. | n.a. | 58 (47.9%) |
NPT - morphologically normal prostate tissue, BPH - benign prostatic hyperplasia, HGPIN - high grade prostatic intraepithelial neoplasia, PCa - prostate carcinoma, n.av. not available and n.a. - not applicable.